The Director of Portfolio Strategy will lead new indication strategy and planning for oncology programs while providing actionable market and competitive intelligence. They will partner with cross-functional teams to guide late-stage clinical development, business development, and commercial planning.
The Corporate Account Director is responsible for establishing strategic relationships with IDNs, Academic Centers, and regional health systems to ensure market access for oncology medicines. They will lead account strategy, negotiate contracts, and collaborate cross-functionally to drive product adoption and clinical pathway inclusion.
The Medical Science Liaison acts as a field-based scientific expert to support oncology therapeutic objectives and communicate scientific data to healthcare professionals. They are responsible for developing territory plans, managing investigator relationships, and providing disease state education across the product lifecycle.
Develop and execute global CMC regulatory strategies for large-molecule products across clinical development, commercialization, and lifecycle management, including preparing and reviewing submissions such as INDs, IMPDs, BLAs, and MAAs. Coordinate with CMC, Supply Chain, Quality, and Regulatory Affairs teams, and support health authority interactions, inspections, regulatory risk assessments, and compliance.
Lead project-level biostatistics strategy and execution for oncology clinical trials, including study design, statistical analysis plans, data analysis, interpretation, and regulatory submissions. Collaborate with clinical, regulatory, operations, data management, and external vendors, while contributing to departmental standards and representing biostatistics in cross-functional and health authority interactions.
The Executive Director will lead the market access account strategy and manage the field account team to ensure broad product access and reimbursement. They will build relationships with key oncology stakeholders and collaborate cross-functionally to integrate market insights into pricing and contracting strategies.
The Senior Director will lead the national field excellence operating model, serving as the primary operational partner to the VP of Sales to ensure launch readiness and effective field execution. This role manages a team of directors and oversees business review infrastructure, performance analysis, and field intelligence loops to support the commercial launch of ivonescimab.
The Senior Manager will collaborate with cross-functional teams to provide GxP compliance advice and ensure quality support for clinical and pre-clinical programs. Responsibilities include managing audits, overseeing CAPA processes, and preparing program teams for health authority inspections.
The Associate Director develops and executes site alliance strategies to strengthen collaboration with clinical institutions and research partners. They also lead start-up optimization and serve as a primary interface to resolve operational issues and improve trial performance.
The Regional Medical Science Director serves as a field-based scientific expert responsible for building relationships with healthcare professionals and supporting clinical development objectives. They act as a primary communicator of scientific data and provide disease state education across the product lifecycle within their assigned territory.
The Director will lead and manage relationships with national and sub-national payers to ensure broad access, reimbursement, and patient affordability for oncology products. They will execute account-level strategies, influence coverage policies, and collaborate with internal teams to support the patient journey and sales pull-through.
Draft, review, and negotiate clinical collaboration, clinical trial, research, supply, and other commercial agreements, while advising internal teams on contractual obligations, risks, and practical alternatives. Coordinate with business units and external parties, support due diligence and contract processes, and provide guidance and training to colleagues.
The Director will lead strategic sourcing, contracting, and vendor governance for clinical operations and global clinical trial portfolios. They will partner with cross-functional teams to optimize study-related spending, manage supplier performance, and ensure compliance across the clinical development lifecycle.
Lead medical affairs and clinical development across multiple oncology programs, including directing Phase 1–3 trials, shaping study strategy, and supporting trial execution and milestones. Collaborate with internal teams and external investigators, contribute to regulatory submissions and safety reviews, and guide scientific communications and clinical documents.
The Regional Marketing Director will develop and execute regional marketing strategies and customer engagement initiatives to support the commercialization of the oncology portfolio. They will act as a key partner to cross-functional teams, including Sales and Medical Affairs, to translate national brand strategies into effective regional execution.
The Director of Market Access Payer Account is responsible for managing national and sub-national payer accounts to ensure broad access, reimbursement, and patient affordability for oncology products. This role involves building relationships with key decision-makers, executing access strategies, and collaborating with internal teams to support product positioning.
The Director leads the global clinical operations analytics strategy, overseeing performance metrics, data governance, and the Veeva Vault Clinical platform. They translate operational data into actionable insights to drive study execution, resource planning, and risk-based decision-making across the organization.
The Corporate Counsel will draft, review, and negotiate a wide range of clinical and commercial contracts to support business objectives and mitigate risk. They will also act as a liaison between internal departments and external parties to ensure efficient legal and contractual operations.
The Associate Director will prepare, edit, and finalize high-quality clinical and regulatory documents to support global development programs. They will also manage document review processes and collaborate with cross-functional teams to ensure regulatory compliance and timely deliverables.
The Senior Director provides global regulatory leadership and strategic oversight for Chemistry, Manufacturing, and Controls (CMC) activities across the company's oncology portfolio. This role is responsible for defining global regulatory strategies for biologics and leading interactions with global Health Authorities to ensure successful product development and licensure.
The Senior Clinical Trial Manager provides strategic leadership and operational oversight for complex global oncology clinical trials from start-up through closeout. They are responsible for managing CRO relationships, ensuring regulatory compliance, and driving patient enrollment and data quality strategies.
The Medical Science Liaison serves as a field-based scientific expert, strategically supporting oncology therapeutic objectives and communicating scientific data to healthcare professionals. They are responsible for developing territory engagement plans, supporting clinical research initiatives, and fostering relationships with external experts.
The Director, Value Outcomes Liaison will cultivate relationships with population-based decision makers to communicate the clinical and economic value of ivonescimab. They will collaborate with internal teams to execute scientific engagement strategies and ensure the inclusion of the therapy in clinical and payer pathways.
The Senior Director of Regulatory Affairs leads global regulatory strategies for oncology products, overseeing IND/CTA approvals and marketing applications. They also provide regulatory leadership, mentor team members, and ensure compliance with relevant laws and guidelines.
Oversee global Phase 3 clinical trials and BLA filings, focusing on protocol design and medical oversight. Lead cross-functional teams to execute clinical development goals and manage investigator engagements.
